Website profile

Biospectrum Asia

BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in the Asia Pacific region.

  • 122articles · 30d
  • 1+ day agolatest article
  • Aug 18, 2026earliest in window
  • 90%with images
  • 258avg words
articles per day
Categories
  • Medical 78
  • Health & Wellness 76
  • Health 45
  • Science & Technology 43
  • Business & Industrial 38
  • Economy, Business & Finance 32
  • Science & Nature 24
  • Finance & Business 16

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


biospectrumasia.com > news > 96 > 28336 > singapore-strengthens-clinical-trials-capacity-in-collaboration-with-who.html

Singapore strengthens clinical trials capacity in collaboration with WHO

6+ day, 11+ hour ago   (150+ words) September 8, 2026 | Tuesday | News Based at the Saw Swee Hock School of Public Health, National University of Singapore, ADVANCE-ID is Singapore’s 13th World Health Organisation (WHO) collaborating centre and joins a global network of institutions designated to support WHO's mandate. ADVANCE-ID will…...


biospectrumasia.com > analysis > 29 > 28327 > 10-decisions-every-life-sciences-ceo-must-make-before-q4-planning-closes.html

10 Decisions Every Life Sciences CEO Must Make Before Q4 Planning Closes

1+ week, 10+ hour ago   (153+ words) September 7, 2026 | Monday | Analysis | By Ankit Kankar | [email protected] Every planning season produces the same quiet moment. The forecasts are built, the templates have gone around twice, and what remains on the table is a short list of questions that no…...


biospectrumasia.com > news > 96 > 28323 > dhl-express-partners-life-science-incubator-to-support-singapore-life-sciences-ecosystem.html

DHL Express partners Life Science Incubator to support Singapore life sciences ecosystem

1+ week, 14+ hour ago   (290+ words) September 7, 2026 | Monday | News DHL Express Singapore has entered into a strategic partnership with Life Science Incubator to support capability building and international growth for Singapore’s life sciences and deep-tech ecosystem. The partnership will focus on LSI@Elementum, Life Science Incubator’s…...


biospectrumasia.com > news > 25 > 28311 > chinas-biocytogen-teams-up-with-qilu-pharma-to-support-drug-development-in-neuroscience.html

China's Biocytogen teams up with Qilu Pharma to support drug development in neuroscience

1+ week, 4+ day ago   (230+ words) BioSpectrum Asia China's Biocytogen teams up with Qilu Pharma to support drug development in neuroscience September 3, 2026 | Thursday | News Using a fully human VHH antibody molecule to support research and development of innovative therapeutics in the neuroscience field Biocytogen Pharmaceuticals (Beijing)…...


biospectrumasia.com > news > 41 > 28310 > thailand-lab-international-2026-opens-in-bangkok-putting-asias-lab-and-life-sciences-innovation-in-focus.html

Thailand LAB INTERNATIONAL 2026 Opens in Bangkok, Putting Asia’s Lab and Life Sciences Innovation in Focus

1+ week, 5+ day ago   (200+ words) September 2, 2026 | Wednesday | News | By Sakshi Kulkarni | [email protected] Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), bringing together the laboratory, biotechnology, chemicals and life sciences ecosystem for three days of technology showcases, industry engagement…...


biospectrumasia.com > opinion > 26 > 28303 > growth-of-personalised-therapies-across-asia-pacific-is-creating-both-opportunity-and-pressure-for-emerging-biotechs.html

“Growth of personalised therapies across Asia-Pacific is creating both opportunity and pressure for emerging biotechs”

1+ week, 6+ day ago   (518+ words) September 1, 2026 | Tuesday | Opinion Before we discuss the market, can you tell us about your role and what drew you to this area of healthcare logistics? How is the rise of personalised therapies reshaping the biopharma landscape across Asia-Pacific? Asia-Pacific is…...


biospectrumasia.com > opinion > 29 > 28275 > building-digital-foundation-for-biomanufacturing.html

Building Digital Foundation for Biomanufacturing

1+ week, 6+ day ago   (261+ words) September 1, 2026 | Tuesday | Opinion | By Neeraja V, Senior Analyst, Advanced SciTech, Everest Group Moving from offline testing to real-time process understanding Digital bioprocessing is also extending into gene-edited cell therapies. In 2026, companies such as Cellares announced a collaboration with Stanford Medicine…...


biospectrumasia.com > news > 54 > 28295 > five-allocators-no-founders-what-the-asia-bio-dealmaking-panel-was-really-pricing.html

Five Allocators, No Founders: What the Asia Bio Dealmaking Panel Was Really Pricing

1+ week, 6+ day ago   (566+ words) September 1, 2026 | Tuesday | News | By Ankit Kankar | [email protected] A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing signal, delivered by the only people in the room who set prices. Before a…...


biospectrumasia.com > news > 26 > 28263 > shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html

Shimadzu invests in OptQC to advance next-generation R&D infrastructure for drug discovery

2+ week, 5+ day ago   (285+ words) BioSpectrum Asia Shimadzu invests in OptQC to advance next-generation R&D infrastructure for drug discovery August 26, 2026 | Wednesday | News This marks Shimadzu's first investment in the quantum technology statup Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from…...


biospectrumasia.com > influencers > 102 > 28246 > china-biotechs-global-breakout-innovation-deals-and-the-next-investment-cycle.html

China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle

3+ week, 4+ hour ago   (344+ words) August 24, 2026 | Monday | Influencers | By Ankit Kankar | [email protected] China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing deals, increasingly competitive innovation, improving financial performance and attractive valuations are drawing renewed investor attention to…...